Robyn M. Barfield

1.3k total citations
25 papers, 1.0k citations indexed

About

Robyn M. Barfield is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Robyn M. Barfield has authored 25 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Radiology, Nuclear Medicine and Imaging, 18 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Robyn M. Barfield's work include Monoclonal and Polyclonal Antibodies Research (19 papers), HER2/EGFR in Cancer Research (12 papers) and Peptidase Inhibition and Analysis (8 papers). Robyn M. Barfield is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (19 papers), HER2/EGFR in Cancer Research (12 papers) and Peptidase Inhibition and Analysis (8 papers). Robyn M. Barfield collaborates with scholars based in United States and South Korea. Robyn M. Barfield's co-authors include David Rabuka, Penelope M. Drake, Lesley Jones, Romas Kudirka, Aaron E. Albers, Stefanie Bañas, Patrick G. Holder, Carolyn R. Bertozzi, Jeanne Baker and Albert W. Garofalo and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Scientific Reports.

In The Last Decade

Robyn M. Barfield

25 papers receiving 930 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robyn M. Barfield United States	17	609	559	556	319	88	25	1.0k
Sai Kiran Sharma United States	23	336 0.6×	615 1.1×	419 0.8×	326 1.0×	33 0.4×	37	1.2k
Alberto Dal Corso Italy	18	637 1.0×	378 0.7×	411 0.7×	316 1.0×	19 0.2×	39	1.0k
Nikolaus Krall Switzerland	13	1.1k 1.8×	455 0.8×	414 0.7×	680 2.1×	46 0.5×	19	1.5k
Michael A. Dechantsreiter Germany	10	690 1.1×	204 0.4×	179 0.3×	345 1.1×	59 0.7×	12	1.1k
Dalton King United States	17	463 0.8×	436 0.8×	314 0.6×	294 0.9×	15 0.2×	26	1.0k
Milind Rajopadhye United States	18	412 0.7×	495 0.9×	233 0.4×	255 0.8×	26 0.3×	32	1.2k
Yasuaki Anami United States	14	365 0.6×	473 0.8×	592 1.1×	124 0.4×	39 0.4×	22	1.0k
Samuele Cazzamalli Switzerland	19	710 1.2×	454 0.8×	601 1.1×	289 0.9×	14 0.2×	57	1.2k
D. Gomika Udugamasooriya United States	16	698 1.1×	199 0.4×	251 0.5×	205 0.6×	60 0.7×	35	1.0k
Elisabeth Lohof Germany	6	1.1k 1.8×	214 0.4×	200 0.4×	647 2.0×	68 0.8×	8	1.4k

Countries citing papers authored by Robyn M. Barfield

Since Specialization

Citations

This map shows the geographic impact of Robyn M. Barfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robyn M. Barfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robyn M. Barfield more than expected).

Fields of papers citing papers by Robyn M. Barfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robyn M. Barfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robyn M. Barfield. The network helps show where Robyn M. Barfield may publish in the future.

Co-authorship network of co-authors of Robyn M. Barfield

This figure shows the co-authorship network connecting the top 25 collaborators of Robyn M. Barfield. A scholar is included among the top collaborators of Robyn M. Barfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robyn M. Barfield. Robyn M. Barfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Mendelsohn, Brian A., Kathleen R. Gogas, Jeffrey N. Higaki, et al.. (2025). Preclinical Characterization of XB010: A Novel Antibody–Drug Conjugate for the Treatment of Solid Tumors that Targets Tumor-Associated Antigen 5T4. Molecular Cancer Therapeutics. 24(12). 1856–1866. 1 indexed citations

2.

Chuprakov, Stepan, Robyn M. Barfield, Maxine Bauzon, et al.. (2021). Tandem-Cleavage Linkers Improve the In Vivo Stability and Tolerability of Antibody–Drug Conjugates. Bioconjugate Chemistry. 32(4). 746–754. 49 indexed citations

3.

Barfield, Robyn M., Yun Cheol Kim, Stepan Chuprakov, et al.. (2020). A Novel HER2-targeted Antibody–drug Conjugate Offers the Possibility of Clinical Dosing at Trastuzumab-equivalent Exposure Levels. Molecular Cancer Therapeutics. 19(9). 1866–1874. 11 indexed citations

4.

Walker, Joshua A., et al.. (2019). Hydrophilic Sequence-Defined Cross-Linkers for Antibody–Drug Conjugates. Bioconjugate Chemistry. 30(11). 2982–2988. 16 indexed citations

5.

Tsui, C. Kimberly, Robyn M. Barfield, Curt R. Fischer, et al.. (2019). CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity. Nature Chemical Biology. 15(10). 949–958. 54 indexed citations

6.

Liu, Junjie, Robyn M. Barfield, & David Rabuka. (2019). Site-Specific Bioconjugation Using SMARTag® Technology: A Practical and Effective Chemoenzymatic Approach to Generate Antibody–Drug Conjugates. Methods in molecular biology. 2033. 131–147. 14 indexed citations

7.

Bauzon, Maxine, et al.. (2019). Maytansine-bearing antibody-drug conjugates induce in vitro hallmarks of immunogenic cell death selectively in antigen-positive target cells. OncoImmunology. 8(4). e1565859–e1565859. 46 indexed citations

8.

Barfield, Robyn M. & David Rabuka. (2018). Leveraging Formylglycine-Generating Enzyme for Production of Site-Specifically Modified Bioconjugates. Methods in molecular biology. 1728. 3–16. 8 indexed citations

9.

Drake, Penelope M., Adam Carlson, Jesse M. McFarland, et al.. (2017). CAT-02-106, a Site-Specifically Conjugated Anti-CD22 Antibody Bearing an MDR1-Resistant Maytansine Payload Yields Excellent Efficacy and Safety in Preclinical Models. Molecular Cancer Therapeutics. 17(1). 161–168. 22 indexed citations

10.

Bañas, Stefanie, et al.. (2016). A simple LC/MRM–MS-based method to quantify free linker-payload in antibody-drug conjugate preparations. Journal of Chromatography B. 1032. 144–148. 9 indexed citations

11.

York, Dona, Jeanne Baker, Patrick G. Holder, et al.. (2016). Generating aldehyde-tagged antibodies with high titers and high formylglycine yields by supplementing culture media with copper(II). BMC Biotechnology. 16(1). 23–23. 38 indexed citations

12.

Kudirka, Romas, Robyn M. Barfield, Jesse M. McFarland, et al.. (2015). Generating Site-Specifically Modified Proteins via a Versatile and Stable Nucleophilic Carbon Ligation. Chemistry & Biology. 22(2). 293–298. 53 indexed citations

13.

Liu, Jiaquan, Jeungphill Hanne, Aaron E. Albers, et al.. (2015). An Efficient Site-Specific Method for Irreversible Covalent Labeling of Proteins with a Fluorophore. Scientific Reports. 5(1). 16883–16883. 17 indexed citations

14.

Drake, Penelope M., Aaron E. Albers, Jeanne Baker, et al.. (2014). Aldehyde Tag Coupled with HIPS Chemistry Enables the Production of ADCs Conjugated Site-Specifically to Different Antibody Regions with Distinct in Vivo Efficacy and PK Outcomes. Bioconjugate Chemistry. 25(7). 1331–1341. 168 indexed citations

15.

Albers, Aaron E., Albert W. Garofalo, Penelope M. Drake, et al.. (2014). Exploring the effects of linker composition on site-specifically modified antibody–drug conjugates. European Journal of Medicinal Chemistry. 88. 3–9. 31 indexed citations

16.

Agarwal, Paresh, Romas Kudirka, Aaron E. Albers, et al.. (2013). Hydrazino-Pictet-Spengler Ligation as a Biocompatible Method for the Generation of Stable Protein Conjugates. Bioconjugate Chemistry. 24(6). 846–851. 127 indexed citations

17.

Jakobsen, Mia Kyed, et al.. (2013). Phosphorylation of Chs2p regulates interaction with COPII. Journal of Cell Science. 126(Pt 10). 2151–6. 12 indexed citations

18.

Hudak, Jason E., Robyn M. Barfield, Patricia Grob, et al.. (2012). Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag. Angewandte Chemie International Edition. 51(17). 4161–4165. 130 indexed citations

19.

Hudak, Jason E., Robyn M. Barfield, Patricia Grob, et al.. (2012). Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag. Angewandte Chemie. 124(17). 4237–4241. 30 indexed citations

20.

Barfield, Robyn M., J. Christopher Fromme, & Randy Schekman. (2009). The Exomer Coat Complex Transports Fus1p to the Plasma Membrane via a Novel Plasma Membrane Sorting Signal in Yeast. Molecular Biology of the Cell. 20(23). 4985–4996. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact